Sector: MedicalInSite Vision Incorporated (AMEX: ISV)
Headlines
- Eyeing Opportunities In Micro-Cap Bio-Pharma Index
Dec 02, 2008 09:54 AM | ACHN, ACUS, ADLR, AKRX, BDSI, BMY
- Microsoft's Cloud Push Lacks Economic Expediency, Sidesteps Catalysts For Ecology-Wide Adoption
Oct 30, 2008 03:04 PM | AAPL, GOOG, ISV, UVV
- Taobao Open Platform Is Coming
Jul 18, 2008 01:20 PM | CGI, CPA, CRM, ISV, SNS
- China Biotech Week in Review: Earnings, Deals and Drug Development
May 31, 2008 10:24 PM | AMAG, AOB, CPHI, ISV, MDCO, SSRX
- InSite Visions Signs Essex to Market AzaSite® in China
May 30, 2008 07:36 PM | ISV
- Inspire Pharma Inspirational
Oct 22, 2007 05:20 PM | AGN, ISPH, ISV
- A Potential Private Equity Vision Care Powerhouse
Aug 09, 2007 02:57 PM | BOL, ISPH, ISV
- NASDAQ Technical Picture - Bulls Regain Momentum
Aug 09, 2007 02:15 AM | AAP, ABBI, ABI, ACF, AIRN, AOB
- InSite Vision Licenses Pfizer Patent For Infection Treatment
Feb 15, 2007 05:04 PM | ISV, PFE
- InSite Vision Receives Notification of NYSE AMEX Panel Decision
Apr 14, 2009 04:51 PM | ISPH, ISV
- InSite Vision Signs International Licensing and Distribution Agreement for AzaSite(®) in Japan and Taiwan With Nitten Pharmaceutical Co., Ltd
Apr 02, 2009 08:24 AM | ISV
- InSite Vision Receives Regulatory Approval for AzaSite(® )in Canada
Mar 31, 2009 08:40 AM | ISV
- InSite Vision Announces Restructuring to Support 2009 Strategic Priorities
Mar 26, 2009 04:01 PM | ISV
- InSite Vision Receives Notice of Delisting From NYSE Alternext US and Will Appeal Decision
Mar 04, 2009 04:02 PM | ISV
- InSite Vision Reports Fourth Quarter and Full Year 2008 Financial Results and Outlines 2009 Priorities
Mar 04, 2009 04:00 PM | ISV
- InSite Vision to Announce Fourth Quarter and Full Year 2008 Financial Results
Feb 26, 2009 11:22 AM | ISV
- InSite Vision Announces FDA Advisory Committee’s Unanimous Recommendation of Approval for New Ophthalmic Product Enabled by InSite’s DuraSite® Technology
Dec 23, 2008 09:04 AM | ISV
- InSite Vision Receives Notification Letter from NYSE Alternext US
Dec 19, 2008 04:36 PM | ISV
- InSite Vision Announces Preliminary Results From Phase 3 Clinical Trial of ISV-502 for the Treatment of Eyelid Inflammation and Infection
Dec 08, 2008 04:41 PM | ISV
- Form 4 INSITE VISION INC For: Feb 17 Filed by: DRAPEAU LOUIS (10K)
Mar 13, 2009 12:56 PM
- Form 4 BOWMAN LYLE M JR For: Feb 17 (10K)
Mar 13, 2009 12:52 PM
- Form 4 HENIGES DAVID For: Feb 17 (10K)
Mar 13, 2009 12:50 PM
- Form 4 INSITE VISION INC For: Sep 23 Filed by: MCINERNEY TIMOTHY (10K)
Sep 25, 2008 10:43 PM
- Form 4 INSITE VISION INC For: Sep 23 Filed by: Melrose Evan S (10K)
Sep 25, 2008 09:49 PM
- Form 4 INSITE VISION INC For: Sep 23 Filed by: LYNCH TIMOTHY P (10K)
Sep 25, 2008 08:59 PM
- Form 3 INSITE VISION INC For: Sep 23 Filed by: LYNCH TIMOTHY P (10K)
Sep 25, 2008 08:55 PM
- Form 4 INSITE VISION INC For: Sep 23 Filed by: Anderson Rick D (10K)
Sep 25, 2008 08:50 PM
- Form 3 INSITE VISION INC For: Sep 23 Filed by: Anderson Rick D (10K)
Sep 25, 2008 08:47 PM
- Form 4 INSITE VISION INC For: Sep 23 Filed by: O'Holla Robert (10K)
Sep 25, 2008 08:45 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ISV
|
Compare to S&P
|
| YTD |
50.85 %
|
53.83 %
|
| 4 Weeks |
66.61 %
|
55.33 %
|
| 12 Weeks |
42.88 %
|
40.90 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -12.50 %
|
|
EPS Growth in Last Year: -550.00 %
|
|
Sales Growth in Last Quarter: 57.29 %
|
|
Sales Growth in Last Quarter: -80.99 %
|
|
